ArticlePituitary2026
"Clinical and biochemical distinctions between organic and idiopathic arginine vasopressin deficiency (AVP-D) in children".
Article in Pituitary, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeArginine Vasopressin Deficiency (AVP-D) is a heterogeneous disorder in childhood, characterized by variable clinical severity and a wide range of underlying etiologies. Early identification of organic forms is crucial, as they are frequently associated with structural hypothalamic–pituitary disease and additional endocrine deficits.
methodsWe retrospectively analyzed 105 children diagnosed with AVP-D over a 25-yearperiod. Clinical features, etiology, baseline biochemical parameters, and results of dynamictesting were collected. Diagnostic evaluation included the water deprivation test and/orarginine-stimulated copeptin assessment. Copeptin concentrations were measured at baselineand after stimulation.
resultsOf the 105 patients (53 males; mean age 7.9 ± 0.5 years), 67 (63.8%) had an organic etiology and 38 (36.2%) an idiopathic form. Children with idiopathic AVP-D were significantly younger at diagnosis (6.3 ± 0.8 vs 8.8 ± 0.6 years; p = 0.01). Organic AVP-D was most commonly caused by craniopharyngioma, germ cell tumors, and congenital hypopituitarism. Associated anterior pituitary hormone deficiencies were present in 92.5% of organic cases versus 23.7% of idiopathic cases (p < 0.0001). Patients with organic AVP-D exhibited significantly higher serum sodium and plasma osmolality at diagnosis, together with markedly lower baseline and stimulated copeptin levels. Diagnosis based solely on baseline biochemical parameters was achieved in 70% of organic cases, compared with 15.8% of idiopathic cases (p< 0.0001).
conclusionOrganic AVP-D in children is characterized by a distinct and more severe biochemical phenotype, with profound copeptin suppression and frequent anterior pituitary involvement. Baseline biochemical assessment, complemented by stimulated copeptin testing when needed, allows accurate etiological stratification and supports a tailored diagnostic approach in pediatric AVP-D.
Indexed as
Identifiers
41984305What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.